Promising Alzheimer's research in Las Vegas

His study is one of many at the Las Vegas Research Center. Another is testing a promising new drug called Aducanumab. In its first 12 months long trial, the drug stopped the progression of Alzheimer's in patients in the early stages. Alzheimer's is what happens when amyloid beta protein creates a …
Source: google